To test whether these tumor cells might form tumors in mice with antitumor immunity, each of the immune mice was challenged with wild type CT26/HER2 cells on the upper left flank, CT26/HER2-A1 cells on the upper right flank and CT26/HER2-A2 cells on the lower right flank. This evidence concerns the gene ERBB2 and neoplasm.